Skip to content

Released Aug 11, 2022, before the open

10-Q filed Aug 12, 2022, 43 days after period end · 0001493152-22-022350

Q2 2022 · 10-Q
Revenue$29.09M+218.2% vs Q2 2021−38.8% vs Q1 2022
Net Income$7.45MN/M vs Q2 2021−40.4% vs Q1 2022
EPS Diluted$0.40N/M vs Q2 2021−41.2% vs Q1 2022
Gross Profit$18,720,000+319.2%
Operating Income$10,587,000N/M
Operating Cash Flowderived$4,821,000+8.5%
Free Cash Flowderived$4,147,000+0.4%
Margins · derived
Gross margin64.3%+15.5 pt vs Q2 2021
Operating margin36.4%+52.3 pt vs Q2 2021
Net margin25.6%+40.9 pt vs Q2 2021

What the release said

The release

Same quarter

MetricQ2 2022Q2 2021Q2 2020Q2 2019
Revenue$29.09M$9.14M$3.62M$1.65M
Net Income$7.45M-$1.40M$70.00K-$1.24M
EPS Diluted$0.40-$0.09$0.01-$0.11

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

ProPhase Labs, Inc. · CIK 868278 · Engraved from SEC EDGAR